Navigation Links
Alexza Reports 2010 Fourth Quarter and Full Year Financial Results and Provides General Corporate Update
Date:3/15/2011

MOUNTAIN VIEW, Calif., March 15, 2011 /PRNewswire/ -- Alexza Pharmaceuticals, Inc. (Nasdaq: ALXA) reported today financial results for the fiscal quarter and year ended December 31, 2010, and provided a general corporate update.  Alexza recorded net income of $25.4 million in the fourth quarter of 2010, while posting a net loss of $1.5 million for the year ended December 31, 2010, as reported in accordance with accounting principles generally accepted in the United States (GAAP), compared to a net loss of $19.8 million and $56.1 million in the quarter and year ended December 31, 2009, respectively.  At December 31, 2010, Alexza had consolidated cash, cash equivalents and marketable securities of $41.4 million.

"All of Alexza has worked very hard over the past months to address the issues raised in the AZ-004 Complete Response Letter," said Thomas B. King, President and CEO of Alexza.  "Based on our End-of-Review meeting with the FDA, ongoing internal work and work with external consultants and advisors, we believe all of the issues raised in the CRL are resolvable.  We remain on track with our plan to resubmit the AZ-004 NDA in July 2011."

Alexza Corporate Update

The following key events occurred since the beginning of the fourth quarter of 2010:

  • Alexza received a Complete Response Letter (CRL) from the U. S. Food and Drug Administration (FDA) to Alexza's New Drug Application (NDA) for AZ-004 Staccato loxapine on October 8, 2010.
  • Alexza reacquired the U.S. and Canadian rights for AZ-004 from Biovail Laboratories International SRL (BLS), now a wholly-owned subsidiary of Valeant Pharmaceuticals International, Inc.  All AZ-004 rights reverted to Alexza, effective January 16, 2011.
  • Alexza completed an End-of-Review meeting with the FDA for the AZ-004 NDA in December 2010, and received the FDA minutes from the
    '/>"/>

  • SOURCE Alexza Pharmaceuticals, Inc.
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8

    Related medicine technology :

    1. Alexza to Announce 2010 Year-End Financial Results on Tuesday, March 15, 2011
    2. Alexza Pharmaceuticals Completes End-of-Review Meeting With FDA for AZ-004 (Staccato® Loxapine) NDA
    3. Alexza Pharmaceuticals Provides Regulatory Update for AZ-004 (Staccato® Loxapine)
    4. Alexza Pharmaceuticals Reports 2010 Third Quarter Financial Results and Provides Business Update
    5. Alexza Pharmaceuticals to Announce 2010 Third Quarter Financial Results on November 9, 2010
    6. Alexza Pharmaceuticals Reacquires U.S. and Canadian Rights for AZ-004 (Staccato® Loxapine)
    7. Valeant Pharmaceuticals Announces That Alexza Pharmaceuticals Has Received a Complete Response Letter for AZ-004 (Staccato® Loxapine) Inhalation Aerosol NDA
    8. Alexza Pharmaceuticals Receives Complete Response Letter for AZ-004 (Staccato® Loxapine) NDA
    9. Alexzas Staccato® Nicotine Licensed to Cypress Bioscience
    10. Alexza Pharmaceuticals to Present at Bank of America Merrill Lynch 2010 Specialty Pharmaceuticals Conference
    11. Alexza Pharmaceuticals Appoints Joseph L. Turner to Its Board of Directors
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:8/29/2014)... Md. , Aug. 29, 2014  United Therapeutics ... the U.S. District Court for the District of ... favor in the company,s case against Sandoz, Inc. regarding ... Peter Sheridan ruled that U.S. Patent No. ... and enjoined Sandoz from marketing its generic product until ...
    (Date:8/29/2014)... 2014 /PRNewswire-iReach/ -- ChemImage will present a workshop focused ... Zealand Forensic Science Society,s 22 nd International ... Adelaide, Australia .  Forensic Scientists will be ... hyperspectral imaging can bring to examination procedures. ... of Product Development at ChemImage, will host a ...
    (Date:8/29/2014)... British Columbia and MENLO PARK, ... DelMar Pharmaceuticals, Inc. (OTCQB: DMPI) ("DelMar" "the ... fiscal year-end financial statements.  The Company recently changed its ... facilitate an application to list its common stock on ... DelMar,s financial statements as filed with the ...
    Breaking Medicine Technology:District Court Decision Received In Remodulin Patent Case 2ChemImage to Discuss Hyperspectral Imaging for Forensic Investigation at the ANZFSS 22nd International Symposium on the Forensic Sciences 2ChemImage to Discuss Hyperspectral Imaging for Forensic Investigation at the ANZFSS 22nd International Symposium on the Forensic Sciences 3DelMar Pharmaceuticals Fiscal 2014 Year End Results and Summary of Recent Developments 2DelMar Pharmaceuticals Fiscal 2014 Year End Results and Summary of Recent Developments 3DelMar Pharmaceuticals Fiscal 2014 Year End Results and Summary of Recent Developments 4DelMar Pharmaceuticals Fiscal 2014 Year End Results and Summary of Recent Developments 5
    ... , Aug. 4 /PRNewswire-Asia-FirstCall/ -- American Oriental,Bioengineering, Inc. (NYSE: ... to improving health through the development, manufacture and,commercialization of a broad range ... to release second quarter 2010,financial results on Monday, August 9, 2010 ... , , ...
    ... SHENZHEN, China , Aug. 4 ... NPD ) ("Nepstar" or "the Company"), the largest ... of directly operated stores,today announced that the State Administration of ... the amount of RMB25.5 million ,( US$3.8 million ) ...
    Cached Medicine Technology:American Oriental Bioengineering to Report Second Quarter 2010 Financial Results on August 9, 2010 2China Nepstar Chain Drugstore Reports One-time Non-recurring Penalty Payment 2China Nepstar Chain Drugstore Reports One-time Non-recurring Penalty Payment 3China Nepstar Chain Drugstore Reports One-time Non-recurring Penalty Payment 4
    (Date:8/30/2014)... 30, 2014 One of the most recent ... the gluten-free diet. Originally meant for sufferers of gluten intolerance ... for people who are looking to get healthier by simply ... is this kind of information erroneous, it also exposes those ... because of a drastic change in their food consumption habits. ...
    (Date:8/30/2014)... Removecomplaints.net, a well-known name in the world ... offer guarantee of results with its complaint removal services. ... of its tremendous track record. The company has successfully ... the world and received recommendation letters from many of ... being asked about the announcement, a senior management executive ...
    (Date:8/30/2014)... (PRWEB) August 30, 2014 Ms. Meriwether’s striking ... She certainly has an impressive resume to boost. ... USA in 2012. However, she’s also a two time ... student. Nana trained for the 2008 Olympics and played ... USA website, “This six-foot beauty from Potomac, Maryland is a ...
    (Date:8/30/2014)... 30, 2014 McLeod's Sunset Park Auto ... repair shop with strong ties to the community celebrates sixty ... to announce they have been chosen by The Tampa ... auto repair. , Tim McLeod’s father, Norris (most know ... years ago. Although his son, Tim runs the day to ...
    (Date:8/30/2014)... As 500 Zoloft lawsuits pending ligation contend the ... mothers, Wright & Schulte LLC recently learned of a remand ... remand in the Zoloft lawsuits was granted to ... involved in one SSRI lawsuit filed jointly under ... defect lawsuit sent back to the Missouri state court in ...
    Breaking Medicine News(10 mins):Health News:“What is Gluten: Three Things You Need to Know Before Adopting a Gluten-Free Diet” Reveals What Readers Need to Know About the Benefits of a Strict Gluten Diet - Vinamy 2Health News:Removecomplaints.net Announces Guaranteed Complaints Removal Services 2Health News:NJ Top Dentists Announces Cover Model for the Healthy Living: Top Dentists Issue 2Health News:McLeod's Sunset Park Auto Service Celebrates 60 Years Honored with Best of South Tampa 2Health News:Group of Plaintiffs in Zoloft Lawsuit Alleging SSRI Caused Birth Defect Are Granted Remand 2Health News:Group of Plaintiffs in Zoloft Lawsuit Alleging SSRI Caused Birth Defect Are Granted Remand 3Health News:Group of Plaintiffs in Zoloft Lawsuit Alleging SSRI Caused Birth Defect Are Granted Remand 4Health News:Group of Plaintiffs in Zoloft Lawsuit Alleging SSRI Caused Birth Defect Are Granted Remand 5
    ... HILLS, Calif., June 11 The Jonsson Cancer,Center ... raising,private funds for highest priority cancer research, hosts ... 21, at the Beverly Wilshire Hotel. FOX,Broadcasting Company ... Humanitarian Award. Jimmy Kimmel hosts the event and ...
    ... LAUREL, N.J., June 11 MedQuist Inc.,(Pink Sheets: MEDQ.PK). ... the District of New Jersey dismissed the South Broward ... and good cause shown,within 60 days, to reopen the ... in the process of informing the court that the ...
    ... Institute of Allergy and Infectious Diseases (NIAID), part of the ... George W. Bush with the Presidential Medal of Freedom at ... , The White House noted today that Dr. Fauci ... knowledge. His efforts to advance our understanding and treatment of ...
    ... PLAINS, NY Experts from throughout the United States will ... the growing crisis of preterm birth. , The conference, ... RADM, USPHS and the Eunice Kennedy Shriver National Institute of ... 16 and 17 in Rockville, MD. It is a ...
    ... While consumers are increasing demand for pork produced ... such conditions carry bacteria and parasites associated with ... A comparison of swine raised in antibiotic-free and ... outdoors without antibiotics had higher rates of three ...
    ... some into remission, study says , , WEDNESDAY, June ... golimumab to weekly doses of methotrexate helped most ... into remission, two new studies show. , The ... biologic therapy drug, were scheduled to be presented ...
    Cached Medicine News:Health News:American Idol Winner David Cook to Perform at and Jimmy Kimmel to Host Jonsson Cancer Center Foundation's 'Taste for a Cure' on June 21 2Health News:MedQuist Announces Dismissal of South Broward Litigation and Appointment of New Interim President & CEO 2Health News:MedQuist Announces Dismissal of South Broward Litigation and Appointment of New Interim President & CEO 3Health News:MedQuist Announces Dismissal of South Broward Litigation and Appointment of New Interim President & CEO 4Health News:Experts to develop national response to growing crisis of premature birth 2Health News:Pigs raised without antibiotics more likely to carry bacteria, parasites 2Health News:Pigs raised without antibiotics more likely to carry bacteria, parasites 3Health News:Pigs raised without antibiotics more likely to carry bacteria, parasites 4Health News:Golimumab Eases Rheumatoid Arthritis Symptoms 2
    ... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
    ... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
    ... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
    ... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
    Medicine Products: